MECHANISM OF ACTIVATION OF PLATELET GPIIB AND GPIIIA
MECHANISM OF ACTIVATION OF PLATELET GPIIB AND GPIIIA
批准号:
2910658
负责人:
Jeffrey W Smith
金额:
$39.0万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-05-01 至 2002-04-30
关键词:
SDS polyacrylamide gel electrophoresis affinity chromatography calpain chemical association chemical kinetics conformation cytoplasm divalent cations enzyme linked immunosorbent assay epidermal growth factor epitope mapping fibrinogen receptors high performance liquid chromatography integrins ligands mass spectrometry molecular site peptide library platelet activation protein binding protein purification protein sequence protein structure function proteolysis western blottings
中文摘要
本研究的长期目标是了解
血小板整合素GPIIb-IIIa的活化。GPIIb-IIIa是
血小板粘附和聚集。 了解其规则
可能对治疗许多心血管疾病很重要
包括心肌梗塞和中风。 GPIIb-IIIa存在于
处于休眠构象的休眠血小板不能结合可溶性
纤维蛋白原。 血小板刺激后,IIb-IIIa能够
结合纤维蛋白原并介导血小板聚集。 虽然
IIb-IIIa的激活是血小板功能的关键,其机制是
激活尚未解决。
该研究的一个假设是,
IIb-IIIa的胞质结构域控制
整联蛋白 这一假设将通过表征
两种纯化形式的胞质结构域的结构差异
IIb-IIIa在激活状态上不同。
本研究的第二个目标是了解
活化依赖性配体与IIb-IIIa的结合。 噬菌体展示将是
用于选择优先结合休眠的配体,
整合素的活性形式。 这项研究的结果可能会
提供了一个结构-活性系列,解释了激活依赖性
配体结合
本研究的第三个目的是了解
整合素活化。 激活是由于配体的增加吗
结合速率或配体解离速率的降低? 这些
研究将在全血小板和纯化形式的
休眠和活跃的IIb-IIIa。
最后一个目标是了解IIb上的二价离子结合位点-
影响激活事件。 将进行结合研究
Ca 2+与休眠和活性IIb-IIIa的纯化构象之间的关系。
该分析的结果应确定哪类离子结合
位点调节整联蛋白的活化。
英文摘要
The long term objective of this study is to understand the mechanism of
activation of the platelet integrin GPIIb-IIIa. GPIIb-IIIa is key to
platelet adhesion and aggregation. An understanding of its regulation
is likely to be important for treating many cardiovascular diseases
including myocardial infarction and stroke. GPIIb-IIIa exists on
resting platelets in a dormant conformation unable to bind soluble
fibrinogen. Upon platelet stimulation, IIb-IIIa becomes capable of
binding fibrinogen and mediating platelet aggregation. Although
activation of IIb-IIIa is key to platelet function, the mechanism its
activation has not been solved.
One hypothesis of the study is that proteolytic cleavage of the
cytoplasmic domains of IIb-IIIa control the activation state of the
integrin. This hypothesis will be tested by characterizing the
structural differences in the cytoplasmic domain of two purified forms
of IIb-IIIa which differ in activation state.
A second goals of the study is to understand the structural basis of
activation-dependent ligand binding to IIb-IIIa. Phage-display will be
used to select ligands that bind preferentially to the dormant and
active forms of the integrin. Results from this study are likely to
provide a structure-activity series explaining activation-dependent
ligand binding.
A third aim of the study is to understand the kinetic aspects of
integrin activation. Does activation result from an increase in ligand
association rate or a decrease in ligand dissociation rate? These
studies will be performed on whole platelets and with purified forms of
dormant and active IIb-IIIa.
A final goal is to understand how the divalent ion binding sites on IIb-
IIIa influence the activation event. Binding studies will be performed
between Ca2+ and purified conformers of dormant and active IIb-IIIa.
Results from this analysis should determine which class of ion binding
sites regulate activation of the integrin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE D - Proteomics Core
-
批准号:10171427
-
项目类别:
-
资助金额:$60.76万
-
财政年份:2016
-
负责人:Jeffrey W Smith
-
依托单位:
CORE D - Proteomics Core
-
批准号:10475596
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2016
-
负责人:Jeffrey W Smith
-
依托单位:
De-orphanizing MMPs in intercelluar interactions
-
批准号:9176901
-
项目类别:
-
资助金额:$52.24万
-
财政年份:2016
-
负责人:Jeffrey W Smith
-
依托单位:
CORE D - Proteomics Core
-
批准号:10641845
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2016
-
负责人:Jeffrey W Smith
-
依托单位:
Core D: Proteomics Core Facility
-
批准号:9072752
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2016
-
负责人:Jeffrey W Smith
-
依托单位:
Systems biology of glutamine utilization in melanoma
-
批准号:8624405
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2014
-
负责人:Jeffrey W Smith
-
依托单位:
Drug Discovery for Fatty Acid Synthase in Oncology
-
批准号:8230593
-
项目类别:
-
资助金额:$50.36万
-
财政年份:2010
-
负责人:Jeffrey W Smith
-
依托单位:
Drug Discovery for Fatty Acid Synthase in Oncology
-
批准号:8447042
-
项目类别:
-
资助金额:$48.33万
-
财政年份:2010
-
负责人:Jeffrey W Smith
-
依托单位:
Drug Discovery for Fatty Acid Synthase in Oncology
-
批准号:8050696
-
项目类别:
-
资助金额:$50.53万
-
财政年份:2010
-
负责人:Jeffrey W Smith
-
依托单位:
Drug Discovery for Fatty Acid Synthase in Oncology
-
批准号:7890649
-
项目类别:
-
资助金额:$52.17万
-
财政年份:2010
-
负责人:Jeffrey W Smith
-
依托单位:
FXR signaling pathway is a valid target for chemoprevention in colorectal cancer
-
批准号:8507168
-
项目类别:
-
资助金额:$42.12万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
FXR signaling pathway is a valid target for chemoprevention in colorectal cancer
-
批准号:7657217
-
项目类别:
-
资助金额:$57.13万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
Project 3: MITF in Drug Resistance and Metabolism in Melanoma
-
批准号:9071970
-
项目类别:
-
资助金额:$42.88万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
FXR signaling pathway is a valid target for chemoprevention in colorectal cancer
-
批准号:8267705
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
FXR signaling pathway is a valid target for chemoprevention in colorectal cancer
-
批准号:8081763
-
项目类别:
-
资助金额:$48.4万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
CENTER ON PROTEOLYTIC PATHWAYS(RMI)
-
批准号:7961277
-
项目类别:
-
资助金额:$33.72万
-
财政年份:2009
-
负责人:Jeffrey W Smith
-
依托单位:
CORE 6 : PROJECT LEADERSHIP AND ADMINISTRATION
-
批准号:7725969
-
项目类别:
-
资助金额:$152.92万
-
财政年份:2008
-
负责人:Jeffrey W Smith
-
依托单位:
CORE 1 TRP2: PROTEASE ACTIVITY IMAGING TECHNOLOGY (PAIT)
-
批准号:7725955
-
项目类别:
-
资助金额:$35.24万
-
财政年份:2008
-
负责人:Jeffrey W Smith
-
依托单位:
CORE 2 DB2: PROTEOLYTIC REGULATION OF HIF-1ALPHA
-
批准号:7725959
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2008
-
负责人:Jeffrey W Smith
-
依托单位:
CORE 2 DB2: PROTEOLYTIC REGULATION OF HIF-1ALPHA
-
批准号:7622857
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2007
-
负责人:Jeffrey W Smith
-
依托单位:
海外基金